Valneva Publishes its FY 2020 Audited Consolidated Financial Statements
Saint-Herblain (France), March 24, 2021 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced …